文献速递前列腺癌

前列腺切除术后挽救性放疗后生化复发患者的解剖学复发模式:一项多中心研究

Anatomical patterns of recurrence following biochemical relapse after post-prostatectomy salvage radiation therapy: a multi-institutional study.
PubMed 文献 · BJU Int · 2017-02-26

该多中心回顾性研究纳入1986至2013年间接受挽救性放疗的574例前列腺切除术后患者,中位随访6.8年。发生临床可检测复发的128例(22%)中,淋巴型、骨型和多灶型分别占17%、50%和31%;转移部位趋向对无远处转移生存和前列腺癌特异性生存有预后意义,10年无远处转移生存率分别为18%、5%和7%(P<0.01)。

要点

  • 挽救性放疗后8年局部、区域和远处失败率分别为2%、6%和21%。
  • 临床可检测复发的128例中,淋巴型、骨型和多灶型分别占17%、50%和31%。
  • 淋巴型、骨型和多灶型10年无远处转移生存率分别为18%、5%和7%(P<0.01)。

核心结论

  • 转移部位趋向对接受挽救性放疗男性的前列腺癌特异性生存有显著预后影响。
  • 与单纯手术的历史数据相比,挽救性放疗后影像学局部失败不常见。
  • 远处失败仍是该患者人群的挑战,需要进一步治疗研究。

研究设计与样本

  • 多中心回顾性研究纳入574例1986至2013年间接受挽救性放疗的前列腺切除术后男性。
  • 解剖学复发模式分为淋巴型(仅淋巴结)、骨型(仅骨)或多灶型(两者均有)。
  • 孤立首次失败部位定义为初始临床检测复发部位且至少3个月保持孤立。

主要发现

  • 挽救性放疗后中位随访6.8年,8年局部、区域和远处失败率分别为2%、6%和21%。
  • 574例中128例(22%)发生临床可检测复发,淋巴型、骨型和多灶型分别占17%、50%和31%。
  • 淋巴型、骨型和多灶型10年无远处转移生存率分别为18%、5%和7%(P<0.01)。
  • 淋巴型、骨型和多灶型10年前列腺癌特异性生存率分别为78%、68%和56%(P<0.01)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To characterise the frequency and detailed anatomical sites of failure for patients receiving post-radical prostatectomy (RP) salvage radiation therapy (SRT). PATIENTS AND METHODS: A multi-institutional retrospective study was performed on 574 men who underwent SRT between 1986 and 2013. Anatomical recurrence patterns were classified as lymphotrophic (lymph nodes only), osteotrophic (bone only), or multifocal if both were present. Isolated first failure sites were defined as sites of initial clinically detected recurrence that remained isolated for at least 3 months. RESULTS: The median follow-up after SRT was 6.8 years. The 8-year rates of local, regional, and distant failure for patients undergoing SRT were 2%, 6%, and 21%, respectively. Of the 22% men (128 of 574) who developed a clinically detectable recurrence, 17%, 50%, and 31% were lymphotrophic, osteotrophic, and multifocal, respectively. The trophic nature of metastases was prognostic for distant metastases-free survival (DMFS) and prostate cancer-specific survival (PCSS); the 10-year rates of DMFS were 18%, 5%, and 7% (P < 0.01), and PCSS were 78%, 68%, and 56% (P < 0.01), for lymphotrophic, osteotrophic, and multifocal failure patterns, respectively. CONCLUSIONS: We demonstrate that trophism for metastatic site has significant prognostic impact on PCSS in men treated with SRT. Radiographic local failure is an uncommon event after SRT when compared to historical data of patients treated with surgery monotherapy. However, distant failure remains a challenge in this patient population and warrants further therapeutic investigation.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Jackson WC, Desai NB, Abugharib AE, et al. Anatomical patterns of recurrence following biochemical relapse after post-prostatectomy salvage radiation therapy: a multi-institutional study. BJU Int. 2017. PMID: 28139024. doi:10.1111/bju.13792

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。